Pesquisas alternativas:
pharmacogenetics genomics » pharmacogenetics genotyping (Expandir a Pesquisa), pharmacogenetics getting (Expandir a Pesquisa), pharmacogenomics genome (Expandir a Pesquisa)
pharmacogenet genomics » pharmaco genomics (Expandir a Pesquisa)
pharmacogenetics genomics » pharmacogenetics genotyping (Expandir a Pesquisa), pharmacogenetics getting (Expandir a Pesquisa), pharmacogenomics genome (Expandir a Pesquisa)
pharmacogenet genomics » pharmaco genomics (Expandir a Pesquisa)
121
“.... Pharmacogenomic studies aim to find such markers within the human genome, and have made some progress in recent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
122
Por Ng, David, Hong, Celine S., Singh, Larry N., Johnston, Jennifer J., Mullikin, James C., Biesecker, Leslie G.
Publicado no Genet Med (2016)
“... and genotype quality of 203 pharmacogenetic variant positions in 973 exomes vs. 5 genomes vs. 5 genotyping chip...”Publicado no Genet Med (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
123
“... gene strategies (eg, genome-wide association scans) has failed to identify additional genes...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
124
“... are implicated in its pathogenesis. Pharmacogenetic and genomic studies investigating NRTI neurotoxicity have...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
125
“... with an inherited component of risk, approximately 50%. Several genome-wide association study (GWAS) reports...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
126
Por Obara, Taku, Abe, Shinya, Satoh, Michihiro, Gutiérrez Ubeda, Sergio Ramón, Yoshimachi, Shoko, Goto, Teruaki
Publicado no Pharmgenomics Pers Med (2015)
“...Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate...”Publicado no Pharmgenomics Pers Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
127
Por Tavis, John E, Donlin, Maureen J, Aurora, Rajeev, Fan, Xiaofeng, Di Bisceglie, Adrian M
Publicado em 2011
“... in up to 50% of patients, so the use of pharmacogenetic biomarkers to predict the outcome of treatment...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
128
129
130
“... on page 1422). We discuss metformin, OCT1, pharmacogenetics, and how the integrative genomics revolution...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
131
Por Gordon, Adam, Fulton, Robert S., Qin, Xiang, Mardis, Elaine R., Nickerson, Deborah A., Scherer, Steve
Publicado no Pharmacogenet Genomics (2016)
“...OBJECTIVES: While the costs associated with whole-genome and whole-exome next-generation sequencing...”Publicado no Pharmacogenet Genomics (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
132
Por Ong, Frank S., Kuo, Jane Z., Wu, Wei-Chi, Cheng, Ching-Yu, Blackwell, Wendell-Lamar B., Taylor, Brian L., Grody, Wayne W., Rotter, Jerome I., Lai, Chi-Chun, Wong, Tien Y.
Publicado em 2013
“...Rapid progress in genomics and nanotechnology continue to advance our approach to patient care...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
133
“... biological system. Pharmacogenetics and genomics are becoming substantially integrated fields...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
134
Por Zhou, Zhiyi, He, Max, Brilliant, Murray, Brautbar, Ariel, Miller, Aaron, Weichelt, Bryan, Lin, Simon
Publicado em 2013
“...BACKGROUND/AIMS: A widely-held vision arising from genomics research is to be able to use...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
135
“... be considered among mechanisms responsible for the effects of pharmacogenetically significant polymorphisms...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
136
137
138
139
Por Dahlin, Amber, Wittwer, Matthias, de la Cruz, Melanie, Woo, Jonathan M., Bam, Rujuta, Scharen-Guivel, Valeska, Flaherty, John, Ray, Adrian S., Cihlar, Tomas, Gupta, Samir K., Giacomini, Kathleen M.
Publicado no Pharmacogenet Genomics (2015)
Obter o texto integralPublicado no Pharmacogenet Genomics (2015)
Obter o texto integral
Obter o texto integral
Artigo
140
Por Anca Liliana Cismaru, Deborah Rudin, Luisa Ibañez, Evangelia Liakoni, Nicolas Bonadies, Reinhold Kreutz, Alfonso Carvajal, Maria Isabel Lucena, Javier Martin, Esther Sancho Ponce, Mariam Molokhia, Niclas Eriksson, EuDAC collaborators, Stephan Krähenbühl, Carlo R. Largiadèr, Manuel Haschke, Pär Hallberg, Mia Wadelius, Ursula Amstutz
Publicado em 2020-10-01
Assuntos:
“...genome-wide association study...”Publicado em 2020-10-01
Obter o texto integral
Artigo